LncRNA PAXIP1‐AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA PAXIP1‐AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 25, Issue 15, Pages 7321-7334
Publisher
Wiley
Online
2021-07-10
DOI
10.1111/jcmm.16761
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathobiology of Pulmonary Artery Hypertension: Role of lncRNAs
- (2020) Kashif Rafiq Zahid et al. CARDIOVASCULAR RESEARCH
- Long Noncoding RNA SNHG6 Functions as an Oncogene in Non-Small Cell Lung Cancer via Modulating ETS1 Signaling
- (2020) Hua Geng et al. OncoTargets and Therapy
- Clinical characteristics of pulmonary hypertension patients living in plain and high‐altitude regions
- (2019) Si Lei et al. Clinical Respiratory Journal
- EDITORIAL: Early evidence for the role of lncRNA TUG1 in vascular remodeling in pulmonary hypertension
- (2019) Sébastien Bonnet et al. CANADIAN JOURNAL OF CARDIOLOGY
- Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression
- (2019) Haiyang Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase
- (2018) Sunil Tomar et al. CANCER LETTERS
- Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression
- (2018) Dan Li et al. ONCOGENE
- WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
- (2018) Yu Pan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long non-coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1-AS1
- (2018) Katharina Jandl et al. JOURNAL OF PATHOLOGY
- Cancer antigen-125 levels correlate with pleural effusions and COPD-related complications in people living at high altitude
- (2018) Shengmei Li et al. MEDICINE
- Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy
- (2017) Min Wu et al. JOURNAL OF CONTROLLED RELEASE
- Novel strategies for treatment of pulmonary arterial hypertension
- (2017) Magdalena Jasińska-Stroschein et al. Postepy Higieny I Medycyny Doswiadczalnej
- Effects of fasudil on pulmonary hypertension in clinical practice
- (2017) Yiqing Zhang et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Pulmonary arterial hypertension: Basic knowledge for clinicians
- (2016) Diana Santos-Ribeiro et al. Archives of Cardiovascular Diseases
- miR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression
- (2016) Yanwei Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PDGF-dependent β-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension
- (2016) Jack Takahashi et al. FEBS LETTERS
- ROCK2 mediates the proliferation of pulmonary arterial endothelial cells induced by hypoxia in the development of pulmonary arterial hypertension
- (2016) FENG QIAO et al. Experimental and Therapeutic Medicine
- A global view of pulmonary hypertension
- (2016) Marius M Hoeper et al. Lancet Respiratory Medicine
- Novel ROCK inhibitors for the treatment of pulmonary arterial hypertension
- (2014) Duncan Shaw et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells
- (2014) Xiaojun Liu et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Targeted therapies in pulmonary arterial hypertension
- (2013) David Montani et al. PHARMACOLOGY & THERAPEUTICS
- Targeting RhoA/ROCK pathway in pulmonary arterial hypertension
- (2012) Sabina Antonela Antoniu EXPERT OPINION ON THERAPEUTIC TARGETS
- Preventive effects of fasudil on adriamycin-induced cardiomyopathy: Possible involvement of inhibition of RhoA/ROCK pathway
- (2011) Na Wang et al. FOOD AND CHEMICAL TOXICOLOGY
- Heparin Inhibits Pulmonary Artery Smooth Muscle Cell Proliferation through Guanine Nucleotide Exchange Factor–H1/RhoA/Rho Kinase/p27
- (2010) Lunyin Yu et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension
- (2010) Hiroshi Fujita et al. HEART AND VESSELS
- The Transcription Factor ETS-1 Mediates Proinflammatory Responses and Neointima Formation in Carotid Artery Endoluminal Vascular Injury
- (2010) Wenguang Feng et al. HYPERTENSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started